Deepak Nitrite Ltd
Deepak Nitrite Ltd
ChemicalsKey Fundamentals
SmallcapSpecialty ChemicalsChemicalsInsights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Deepak Nitrite Ltd insights
44 extracted metrics + investor summaries across FY15–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Weaknesses
2- Company has a low return on equity of 12.8% over last 3 years.
- Company might be capitalizing the interest cost
Growth Rate
AI Analysis — Bull vs Bear
Deepak Nitrite trades at a market cap of ₹24,255 crore with a PE of 42.5x on the back of a 10-year sales CAGR of 19% but a recent 3-year profit CAGR of -13%. FY25 total income stood at ~₹8,366 crore (up 8% YoY), while return on equity has declined from a 5-year average of 18% to 10% in the last year, reflecting margin compression from Chinese competition and pricing pressure.
- Strong long-term revenue compounder — 10-year compounded sales CAGR of 19% and 10-year profit CAGR of 24%, demonstrating structural demand for its product portfolio
- Q1 FY27 showed sharp recovery with PAT tripling to ₹345 crore (up 209% YoY) and EBITDA margins doubling to ~21% from ~11% in Q3 FY25, indicating cyclical trough may be behind
- Massive capex pipeline of ₹2,500 crore for a 240 KTA Bisphenol-A (BPA) plant, strengthening vertical integration from Cumene to Phenol to BPA to Polycarbonate resins
- Near-term net debt remains low with debt-to-equity at ~0.22x (₹50-60 crore net debt against net worth of ~₹3,126 crore as of FY25), providing balance sheet headroom for expansion
- Domestic revenue share of ~84% provides insulation from global trade disruptions and tariff risks
- TTM profit growth of 31% signals an earnings inflection after two years of compression, potentially justifying the elevated PE multiple
- Multiple new projects — nitric acid, MIBK/MIBC, hydrogenation, acetophenone — expected to commission in FY26, adding incremental revenue streams
- 10-year stock CAGR of 33% reflects the market's long-term re-rating of the company from a mid-cap chemical player to a diversified specialty platform
- PE ratio of 42.5x is elevated relative to a last-year ROE of only 10% and 3-year average ROE of 12.8%, implying the stock prices in significant recovery that is not yet fully visible in trailing earnings
- 3-year compounded profit CAGR is -13% and 5-year profit CAGR is -7%, indicating a prolonged earnings decline despite revenue holding up
- Intense competition from Chinese chemical imports has pressured spreads in both the Phenolics and Advanced Intermediates segments, with Q3 FY25 revenue declining 5.3% YoY
- Potential interest cost capitalization (flagged concern) may overstate reported profitability during the heavy capex phase of ₹1,500-4,000 crore annually over FY26-FY28
- Stock has delivered negative returns over 1-year (-5%), 3-year (-5%), and 5-year (-4%) CAGR periods, suggesting prolonged underperformance despite market tailwinds
- Dividend yield of just 0.44% offers minimal income support while investors wait for capex projects to generate returns
- FY26 annual revenue declined ~4.8% to ₹7,887 crore, showing that recovery is uneven and not yet sustained on a full-year basis
- Capex of ₹3,000-4,000 crore planned for FY27-28 will likely increase leverage and could strain free cash flow if margin recovery stalls
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- Q1FY26 profit surges 207% YoY Aug 4
Consolidated net profit jumped to ₹345.01 crore (up 207% YoY) with revenue rising 36% to ₹2,577.60 crore, driven by strong Phenolics segment performance.
- ₹2,500 Cr BPA plant approved Aug 4
Subsidiary Deepak Chem Tech approved a ₹2,500 crore investment for a 240 KTA Bisphenol A plant, integrating the value chain from Cumene to Polycarbonate resin.
- ₹11,500 Cr polycarbonate project advances Aug 7
The integrated polycarbonate project targets H2 FY29 commissioning with ~₹1,200 crore spent so far; MIBK, MIBC, and Acetophenone units set for August launch. Capex of ₹1,000–1,500 crore planned for FY27 and ₹3,000 crore for FY28.
- New CEO for Advanced Intermediates Aug 4
Lohit Shringi appointed CEO of Advanced Intermediates Business effective August 4, 2026, bringing 27+ years of experience from PCBL and DuPont.
- ₹7.50 dividend approved at AGM Aug 5
Shareholders approved a ₹7.50 per share dividend and key board appointments at the 55th AGM held August 5, 2026.
- Independent Director exits after term Aug 7
Dileep Choksi ceased as Independent Director effective August 7, 2026, after completing his second term. Board now comprises 13 members.
- $78.43M guarantee for Oman unit Jul 23
Deepak Nitrite executed a corporate guarantee for a $78.43 million term loan for subsidiary Deepak Oman Industries (SFZ) LLC, favoring Bank Muscat SAOG.
- Promoter shares fully unencumbered Jul 21
Deepak C. Mehta confirmed no encumbrance on promoter shares for FY26 in a declaration submitted to NSE.
- Q1 FY27 earnings call scheduled Jul 24
Earnings conference call set for August 6, 2026, at 3:30 PM IST with senior management including Deputy MD Maulik Mehta and CFO Somsekhar Nanda.
TL;DR: Deepak Nitrite is executing strongly with a 207% YoY profit surge in Q1FY26 and aggressive capex plans totaling ₹11,500 crore for its polycarbonate value chain integration. New leadership appointments and near-term unit launches signal operational momentum. No material headwinds are visible in recent news flow. The trend is clearly improving, with the key watch item being timely execution of large capital projects through FY28-29.
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,768 | 1,778 | 2,009 | 2,126 | 2,167 | 2,032 | 1,903 | 2,180 | 1,890 | 1,902 | 1,975 | 2,120 | 2,578 |
| Expenses | 1,559 | 1,476 | 1,705 | 1,825 | 1,858 | 1,734 | 1,735 | 1,863 | 1,700 | 1,698 | 1,764 | 1,744 | 2,037 |
| Operating Profit | 210 | 302 | 305 | 301 | 309 | 298 | 169 | 317 | 190 | 204 | 211 | 376 | 540 |
| OPM % | 12% | 17% | 15% | 14% | 14% | 15% | 9% | 15% | 10% | 11% | 11% | 18% | 21% |
| Other Income | 32 | 17 | 14 | 99 | 19 | 21 | 21 | 23 | 25 | 20 | -4 | 7 | 14 |
| Interest | 2 | 3 | 3 | 4 | 6 | 6 | 6 | 9 | 8 | 8 | 11 | 19 | 23 |
| Depreciation | 38 | 39 | 42 | 46 | 47 | 48 | 48 | 51 | 51 | 53 | 58 | 63 | 64 |
| PBT | 202 | 277 | 274 | 349 | 275 | 264 | 135 | 279 | 155 | 163 | 138 | 301 | 468 |
| Tax % | 26% | 26% | 26% | 27% | 26% | 26% | 27% | 27% | 27% | 27% | 28% | 27% | 26% |
| Net Profit | 150 | 205 | 202 | 254 | 203 | 194 | 98 | 202 | 112 | 119 | 100 | 220 | 345 |
| EPS in Rs | 10.99 | 15.04 | 14.81 | 18.61 | 14.85 | 14.24 | 7.19 | 14.84 | 8.23 | 8.7 | 7.32 | 16.11 | 25.3 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,327 | 1,373 | 1,371 | 1,651 | 2,700 | 4,230 | 4,360 | 6,802 | 7,972 | 7,682 | 8,282 | 7,887 | 8,575 |
| Expenses | 1,187 | 1,204 | 1,231 | 1,447 | 2,278 | 3,194 | 3,108 | 5,196 | 6,680 | 6,555 | 7,187 | 6,900 | 7,243 |
| Operating Profit | 140 | 169 | 139 | 204 | 421 | 1,035 | 1,252 | 1,607 | 1,292 | 1,127 | 1,095 | 987 | 1,331 |
| OPM % | 11% | 12% | 10% | 12% | 16% | 24% | 29% | 24% | 16% | 15% | 13% | 13% | 16% |
| Other Income | 1 | 0 | 80 | 7 | 11 | 29 | 20 | 42 | 46 | 156 | 84 | 44 | 36 |
| Interest | 38 | 40 | 37 | 47 | 87 | 118 | 77 | 36 | 27 | 15 | 31 | 49 | 61 |
| Depreciation | 36 | 40 | 48 | 53 | 78 | 140 | 153 | 178 | 166 | 166 | 195 | 225 | 237 |
| PBT | 67 | 89 | 135 | 111 | 268 | 806 | 1,042 | 1,434 | 1,146 | 1,102 | 953 | 757 | 1,070 |
| Tax % | 21% | 29% | 28% | 29% | 35% | 24% | 26% | 26% | 26% | 26% | 27% | 27% | — |
| Net Profit | 53 | 63 | 96 | 79 | 174 | 611 | 776 | 1,067 | 852 | 811 | 697 | 551 | 783 |
| EPS in Rs | 5.06 | 5.39 | 7.37 | 5.79 | 12.73 | 44.8 | 56.88 | 78.2 | 62.47 | 59.45 | 51.12 | 40.36 | 57.43 |
| Div. Payout % | 20% | 22% | 16% | 22% | 16% | 10% | 10% | 9% | 12% | 13% | 15% | 19% | — |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 21 | 23 | 26 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 |
| Reserves | 325 | 450 | 689 | 895 | 1,044 | 1,545 | 2,319 | 3,311 | 4,063 | 4,769 | 5,361 | 5,810 |
| Borrowings | 545 | 529 | 724 | 987 | 1,187 | 1,107 | 590 | 315 | 73 | 286 | 1,267 | 1,638 |
| Other Liabilities | 235 | 295 | 350 | 684 | 677 | 538 | 630 | 779 | 967 | 1,012 | 1,053 | 1,180 |
| Total Liabilities | 1,125 | 1,296 | 1,789 | 2,592 | 2,935 | 3,217 | 3,567 | 4,432 | 5,129 | 6,095 | 7,708 | 8,654 |
| Fixed Assets | 549 | 594 | 586 | 588 | 1,716 | 1,832 | 1,864 | 1,963 | 1,942 | 2,293 | 2,457 | 3,270 |
| CWIP | 44 | 36 | 349 | 955 | 34 | 172 | 220 | 122 | 301 | 774 | 1,649 | 1,828 |
| Investments | 3 | 87 | 118 | 32 | 2 | 2 | 189 | 439 | 379 | 122 | 511 | 213 |
| Other Assets | 530 | 580 | 736 | 1,018 | 1,183 | 1,210 | 1,293 | 1,908 | 2,508 | 2,907 | 3,091 | 3,343 |
| Total Assets | 1,125 | 1,296 | 1,789 | 2,592 | 2,935 | 3,217 | 3,567 | 4,432 | 5,129 | 6,095 | 7,708 | 8,654 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 108 | 167 | 49 | 183 | 60 | 765 | 1,002 | 824 | 650 | 874 | 625 | 539 |
| Investing | -89 | -169 | -353 | -525 | -163 | -428 | -396 | -424 | -276 | -717 | -1,489 | -669 |
| Financing | -22 | 4 | 305 | 345 | 96 | -338 | -599 | -386 | -359 | 44 | 806 | 193 |
| Net Cash Flow | -3 | 2 | 1 | 4 | -6 | -1 | 7 | 14 | 15 | 200 | -59 | 64 |
| Free Cash Flow | 18 | 81 | -192 | -438 | -194 | 349 | 788 | 638 | 290 | 110 | -494 | -658 |
| CFO/OP | 87 | 110 | 47 | 103 | 28 | 93 | 99 | 73 | 70 | 101 | 77 | 74 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 86 | 83 | 96 | 91 | 78 | 53 | 63 | 61 | 60 | 62 | 56 | 70 |
| Inventory Days | 47 | 54 | 75 | 118 | 94 | 63 | 64 | 53 | 62 | 54 | 59 | 57 |
| Days Payable | 48 | 59 | 95 | 176 | 106 | 57 | 72 | 46 | 46 | 38 | 33 | 35 |
| Cash Conversion Cycle | 85 | 79 | 76 | 32 | 66 | 59 | 56 | 67 | 76 | 77 | 82 | 92 |
| Working Capital Days | -3 | -28 | -49 | -29 | 35 | 33 | 57 | 57 | 70 | 70 | 64 | 61 |
| ROCE % | — | 14% | 8% | 10% | 17% | 38% | 40% | 44% | 30% | 22% | 16% | 11% |
Documents
Frequently Asked Questions about Deepak Nitrite Ltd
What does Deepak Nitrite Ltd do?
Where is Deepak Nitrite Ltd (DEEPAKNTR) listed?
Which sector does Deepak Nitrite Ltd belong to?
What is the market capitalisation of Deepak Nitrite Ltd?
What is the PE ratio of Deepak Nitrite Ltd?
What is the 52-week high and low of Deepak Nitrite Ltd?
Does Deepak Nitrite Ltd pay dividends?
What is the Return on Equity (ROE) of Deepak Nitrite Ltd?
How can I research Deepak Nitrite Ltd on Tapetide?
Company Information
Incorporated in 1970, Deepak Nitrite Ltd manufactures Basic Intermediates, Fine & Speciality Chemicals, Performance Products, and Phenolics[1]